Therapeutic efficacy of Phyllanthus emblica- coated iron oxide nanoparticles in A549 lung cancer cell line

Nanomedicine (Lond). 2019 Sep;14(17):2355-2371. doi: 10.2217/nnm-2019-0111. Epub 2019 Aug 15.

Abstract

Aim: Present work was undertaken to fabricate iron oxide nanoparticles (IONPs) using a green approach for increased therapeutic efficacy. Materials & methods: Two types of IONPs were synthesized, one without any coating (IONPUC) and other coated with Phyllanthus emblica (Amla) fruit extract (IONPA). Both the IONPs were characterized using different techniques and therapeutic efficacy was evaluated in A549 human lung cancer cell line. Results: IONPA were smaller in size with better dispersibility compared with IONPUC. They induced increased reactive oxygen species production, higher DNA damage and apoptosis, which resulted in increased toxicity to cancer cells in comparison to IONPUC. Conclusion: Higher uptake of IONPA and active components coating the surface, may be responsible for the increased therapeutic efficacy in cancer cells.

Keywords: amla extract; green synthesis; iron oxide; iron oxide nanoparticle; lung cancer; nanoparticle; nanotherapy; phytochemical screening; reactive oxygen species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Coated Materials, Biocompatible / chemistry
  • Coated Materials, Biocompatible / therapeutic use
  • Ferric Compounds / chemistry
  • Ferric Compounds / therapeutic use*
  • Humans
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Nanomedicine
  • Nanoparticles / chemistry
  • Nanoparticles / therapeutic use*
  • Phyllanthus emblica / chemistry*
  • Plant Extracts / chemistry
  • Plant Extracts / therapeutic use*
  • Reactive Oxygen Species / metabolism

Substances

  • Coated Materials, Biocompatible
  • Ferric Compounds
  • Plant Extracts
  • Reactive Oxygen Species
  • ferric oxide